Quest Diagnostics (DGX) Reports In-Line Q4 EPS
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $236.23 +1.84%
Revenue Growth %: +7.8%
Financial Fact:
Dividends per common share: 0.4
Today's EPS Names:
YRD, CAG, CALM, More
Revenue Growth %: +7.8%
Financial Fact:
Dividends per common share: 0.4
Today's EPS Names:
YRD, CAG, CALM, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.19, in-line with the analyst estimate of $1.19. Revenue for the quarter came in at $1.85 billion versus the consensus estimate of $1.85 billion.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron reports Q4 today: Why Lynx Equity sees massive upside
- TD Cowen Reiterates Buy Rating on Medtronic, Inc. (MDT), sees bullish earnings setup
- cBrain partners with Djoef, raises 2026 earnings forecast
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
